Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03260569 · ClinicalTrials.gov registry record · Phase 3
Inhaled Nitric Oxide in Brain Injury
A Phase 3 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 3
- Development phase
- 13
- Enrollment target
NCT03260569 is a Phase 3 study that has completed, run by University of Cincinnati. The registered enrollment target is 13 participants.
The verdict
NCT03260569, a Phase 3 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study will evaluate the changes in respiratory mechanics following traumatic brain injury and determine the effect of inhaled nitric oxide on gas exchange.
Interventions
- DRUG Placebo
- DRUG Inhaled Nitric Oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-12-12 |
| Est. Completion | 2023-12-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03260569
The ClinicalTrials.gov registry entry for NCT03260569 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03260569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03260569 about?
NCT03260569 is a clinical study titled "Inhaled Nitric Oxide in Brain Injury". This study will evaluate the changes in respiratory mechanics following traumatic brain injury and determine the effect of inhaled nitric oxide on gas exchange.
What is the current status of trial NCT03260569?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 13 participants. The study started on 2018-12-12. Estimated completion is 2023-12-28.
What interventions are being tested in trial NCT03260569?
The interventions under investigation include: Placebo (DRUG), Inhaled Nitric Oxide (DRUG).
Who is sponsoring clinical trial NCT03260569?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.